Vik Arora, PhD, DABT
Company: Voyager Therapeutics
Job title: Vice President of Toxicology
Seminars:
IND-Enabling Toxicology and FIH Dose Extrapolation Considerations 1:45 pm
Regulatory expectations for nonclinical package to support AAV-based gene therapy IND Investigating immunogenicity and the impact it has on dosing FIH Dose Extrapolation ConsiderationsRead more
day: Conference Day One